Evidence map›Paper›PMID 16249884›Full record

ArticleHuman genetics2006

Disruptions of the novel KIAA1202 gene are associated with X-linked mental retardation.

Olivier Hagens, Aline Dubos, Fatima Abidi, Gotthold Barbi, Laura Van Zutven, Maria Hoeltzenbein, Niels Tommerup, Claude Moraine, Jean-Pierre Fryns, Jamel Chelly and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Human genetics, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Elucidating the role ofFrontiers in immunology · 2025
    Article
  5. Article
  6. Review
  7. X-linked variations inJournal of medical genetics · 2023
    Article
  8. Frontiers in molecular neuroscience · 2022
    Article
  9. Editorial: Sub-molecular mechanism of genetic epilepsy.Frontiers in molecular neuroscience · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 8 countries.

Olivier HagensDepartment of Human Molecular Genetics, Max Planck Institute for Molecular Genetics, Ihnestrasse 73, 14195, Berlin, Germany.
Aline Dubos
Fatima Abidi
Gotthold Barbi
Laura Van Zutven
Maria Hoeltzenbein
Niels Tommerup
Claude Moraine
Jean-Pierre Fryns
Jamel Chelly
Hans van Bokhoven
Jozef Gécz
Hélène Dollfus
Hans-Hilger Ropers
Charles E Schwartz
Rita de Cassia Stocco Dos Santos
Vera Kalscheuer
André Hanauer
Max Planck Institute for Molecular Genetics · DEGreenwood Genetic Center · USInserm · FRCentre National de la Recherche Scientifique · FRHôpitaux Universitaires de Strasbourg · FRInstitut de génétique et de biologie moléculaire et cellulaire · FRKU Leuven · BERadboud University Nijmegen · NLUniversidade de Taubaté · BRUniversität Ulm · DEUniversity of Adelaide · AUUniversity of Copenhagen · DK

Funding

X-LINKED MENTAL RETARDATION: LINKAGE &CLINICAL STUDIESR01HD026202 · NICHD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SCHWARTZ, CHARLES E · 1990 to 2006
$7.9M
NICHD NIH HHS HD26202
6 · The paper itself

Abstract

The extensive heterogeneity underlying the genetic component of mental retardation (MR) is the main cause for our limited understanding of the aetiology of this highly prevalent condition. Hence we set out to identify genes involved in MR. We investigated the breakpoints of two balanced X;autosome translocations in two unrelated female patients with mild/moderate MR and found that the Xp11.2 breakpoints disrupt the novel human KIAA1202 (hKIAA1202) gene in both cases. We also identified a missense exchange in this gene, segregating with the Stocco dos Santos XLMR syndrome in a large four-generation pedigree but absent in >1,000 control X-chromosomes. Among other phenotypic characteristics, the affected males in this family present with severe MR, delayed or no speech, seizures and hyperactivity. Molecular studies of hKIAA1202 determined its genomic organisation, its expression throughout the brain and the regulation of expression of its mouse homologue during development. Transient expression of the wild-type KIAA1202 protein in HeLa cells showed partial colocalisation with the F-actin based cytoskeleton. On the basis of its domain structure, we argue that hKIAA1202 is a new member of the APX/Shroom protein family. Members of this family contain a PDZ and two ASD domains of unknown function and have been shown to localise at the cytoskeleton, and play a role in neurulation, cellular architecture, actin remodelling and ion channel function. Our results suggest that hKIAA1202 may be important in cognitive function and/or development.

Indexed as

MutationAmino Acid SequenceAnimalsBase SequenceChromosomes, Human, XCloning, MolecularDNAHumansMiceMolecular Sequence DataMutagenesisSequence Homology, Amino AcidSequence Homology, Nucleic AcidSubcellular FractionsTranslocation, GeneticX-Linked Intellectual DisabilityDNA

Identifiers

PMID16249884
OpenAlexW2148475741

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.